Westmount Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
2,355
+211
| +10% | +$164K | 0.5% | 46 |
|
|
2025
Q1 | $1.77M | Buy |
2,144
+75
| +4% | +$61.9K | 0.54% | 43 |
|
|
2024
Q4 | $1.6M | Sell |
2,069
-268
| -11% | -$207K | 0.49% | 44 |
|
|
2024
Q3 | $2.07M | Buy |
2,337
+1,222
| +110% | +$1.08M | 0.62% | 36 |
|
|
2024
Q2 | $1.02M | Buy |
1,115
+48
| +4% | +$43.9K | 0.34% | 63 |
|
|
2024
Q1 | $830K | Buy |
1,067
+45
| +4% | +$35K | 0.3% | 74 |
|
|
2023
Q4 | $596K | Buy |
1,022
+107
| +12% | +$62.4K | 0.24% | 88 |
|
|
2023
Q3 | $491K | Buy |
915
+117
| +15% | +$62.8K | 0.22% | 105 |
|
|
2023
Q2 | $374K | Sell |
798
-18
| -2% | -$8.44K | 0.16% | 127 |
|
|
2023
Q1 | $280K | Buy |
816
+101
| +14% | +$34.7K | 0.13% | 142 |
|
|
2022
Q4 | $262K | Buy |
+715
| New | +$262K | 0.14% | 145 |
|